Cancer 2000 Mar 1;88(5 Suppl):1217-23
The excess burden of breast carcinoma in minority and medically underserved
communities: application, research, and redressing institutional racism.
Shinagawa SM.
Chair, Intercultural Cancer Council, Houston, Texas, USA.
BACKGROUND: In 1998, the American Cancer Society, the
National Cancer Institute, and the Centers for Disease Control and Prevention
reported an overall downward trend in cancer incidence and mortality between
1990 and 1995 for all cancers combined. Many minority and medically underserved
populations, however, did not share equally in these improvements.
METHODS: A review of surveillance and other reports and
recent literature on disparities in cancer incidence and mortality in
minority and medically underserved communities was conducted 1) to ascertain
the extent to which these communities bear an excess cancer burden, and
2) to explore the macrosocietal and microinstitutional barriers to equitable
benefits in cancer health care delivery.
RESULTS: Tragic disparities in cancer incidence and mortality
in minority and medically underserved communities continue to be inadequately
addressed. Overall improvements in U.S. cancer incidence and mortality
rates are not shared equally by all segments of our society. While numerous
individual and cultural barriers to optimal cancer control and care exist
in minority and medically underserved communities, a major factor precluding
these populations from sharing equally in advances in cancer research
is prevailing societal and institutional racism.
CONCLUSIONS: Immediate and equitable application of existing
cancer control interventions and quality treatment options will significantly
decrease cancer incidence and mortality. Enhanced surveillance efforts
and a greater investment in targeted cancer research in those communities
with the greatest disparities must be employed immediately if we are to
achieve the goal of the president of the United States of eliminating
racial and ethnic disparities in cancer and other diseases by 2010. Unless
we acknowledge and redress institutionalized racism, the miscarriage of
health justice will be perpetuated while celebrated advances in cancer
research leading to declining incidence and mortality rates continue to
evade our nation's minority and medically underserved communities.
Copyright 2000 American Cancer Society.
Publication Types: Review; Review, Tutorial
PMID: 10705358 [PubMed - indexed for MEDLINE]